Actively Recruiting

Phase Not Applicable
Age: 18Years - 44Years
All Genders
NCT03663361

Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation

Led by Phillip Gribble · Updated on 2026-02-20

150

Participants Needed

2

Research Sites

346 weeks

Total Duration

On this page

Sponsors

P

Phillip Gribble

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this project is to compare a novel sensorimotor ankle rehabilitation training (SMART) protocol for Lateral ankle sprains (LASs) against a standard of care (SOC) protocol to determine if it is more successful at producing successful one-year outcomes and lower rates of re-injury and improved health. This will address the identified needs for evidence-support and reintegration strategies to improve understanding of the management of patient rehabilitation strategies throughout the rehabilitation process following neuromusculoskeletal injury. The project will validate an innovative rehabilitation approach while providing metrics of success using a variety of clinical and innovative markers.

CONDITIONS

Official Title

Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation

Who Can Participate

Age: 18Years - 44Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Initiating rehabilitation for a first-time acute grade I, II, or III lateral ankle sprain
  • Injury sustained within 72 hours before study enrollment
  • Diagnosed by a physician, medic, athletic trainer, physical therapist, or other medical personnel as having a lateral ankle sprain
Not Eligible

You will not qualify if you...

  • Personal or family history of epilepsy or seizures
  • History of migraine headaches
  • Ocular foreign body, increased intracranial pressure, open head injury, or significant closed head injury
  • Cochlear implants
  • Implanted brain stimulators, aneurysm clips, or other metal in the head (except mouth)
  • Implanted medication pumps, pacemakers, or intracardiac lines
  • Current use of tricyclic antidepressants, neuroleptic agents, or other drugs that lower seizure threshold
  • History of diagnosed major psychiatric disorder
  • History of illicit drug use
  • Current alcohol abuse or withdrawal from alcohol abuse
  • History of heart disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Kentucky

Lexington, Kentucky, United States, 40506

Actively Recruiting

2

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

Loading map...

Research Team

K

Kyle Kosik, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here